Authors' comment on: effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis
Al-Bawardy, Badr Quraishi, Mohammed Nabil
Al-Bawardy, Badr
Quraishi, Mohammed Nabil
Abstract
No abstract available
MIDER Authors
Date
2025-03-24
Type
Correspondence
Subject
Inflammatory bowel diseases, Cholangitis, sclerosis, Vancomycin
Collections
Citation
Al-Bawardy B, Quraishi MN. Authors' comment on: effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis. Therap Adv Gastroenterol. 2025 Mar 24;18:17562848251328606. doi: 10.1177/17562848251328606.
Journal / Source Title
Therapeutic Advances in Gastroenterology
DOI
10.1177/17562848251328606
PMID
40144790
Publisher
SAGE Publications
Publisher’s URL
https://journals.sagepub.com/home/tag